Tag Archives: S&P Emerging BMI
Do Active Funds Outperform in Less-Efficient Markets?
Active managers sometimes tout their ability to select stocks in markets that are considered less informationally efficient and those that offer larger rewards to successful stock pickers. Smaller companies and those in emerging markets are typically presented as examples. What are the grounds for debate, and what do over 20 years of SPIVA® Scorecards tell…
- Categories Equities
- Other Tags
The Global Equity Landscape: Struggles and Surprises in 2024
U.S. equity markets enjoyed a great year in 2024, but the returns in many developed equity markets were found wanting in relative terms and, in many cases, absolute terms as well. With just a few trading days left in 2024, the S&P Developed BMI has gained 22% YTD as of Dec. 13, 2024, with all…
- Categories Equities
- Other Tags
Clash of Titans: Diverging Global and Emerging Market Mid-Year Active Performance
Much of recent market commentary has been focused on market concentration concerns,1 thanks to the dominance of mega-cap stocks in the U.S., with the S&P 500® Top 50 outperforming the S&P 500 by 5% for the 12 months ending in September 2024. But as we’ve noted in our inaugural SPIVA® Global Mid-Year 2024 Scorecard, concentration…
- Categories Equities
-
Other Tags
2024, Active vs. Passive, Anu Ganti, core, emerging markets, Global equity, IIS, institutional investor, passive investing, S&P 500 Top 50, S&P China BMI, S&P Developed BMI, S&P Emerging ex-China BMI, S&P World Ex-U.S. Index, S&P World Index, S&P/IFCI Composite, SPIVA, topposts2024, U.S. Equity, US FA
- Categories
- Equities
- Other Tags
- 2024, Active vs. Passive, Anu Ganti, core, emerging markets, Global equity, IIS, institutional investor, passive investing, S&P 500 Top 50, S&P China BMI, S&P Developed BMI, S&P Emerging ex-China BMI, S&P World Ex-U.S. Index, S&P World Index, S&P/IFCI Composite, SPIVA, topposts2024, U.S. Equity, US FA